This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

Indian Supreme Court to hear Novartis dispute over generic drugs


India’s highest court is set to hear a long-running dispute between Novartis and the country’s government, which has prevented the pharma company from patenting its cancer drug Gleevec.

Novartis, pharmaceuticals, Gleevec, healthcare, India Patent Act


Payment types accepted